These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37010047)

  • 1. External trigeminal neurostimulation in patients with chronic migraine.
    Trimboli M; Marsico O; Troisi L; Fasano F
    Pain Manag; 2023 Mar; 13(3):185-192. PubMed ID: 37010047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial.
    Di Fiore P; Bussone G; Galli A; Didier H; Peccarisi C; D'Amico D; Frediani F
    Neurol Sci; 2017 May; 38(Suppl 1):201-206. PubMed ID: 28527053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy.
    Chou DE; Gross GJ; Casadei CH; Yugrakh MS
    Neuromodulation; 2017 Oct; 20(7):678-683. PubMed ID: 28580703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly
    Riederer F; Penning S; Schoenen J
    Pain Ther; 2015 Oct; 4(2):135-47. PubMed ID: 26467451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients.
    Danno D; Iigaya M; Imai N; Igarashi H; Takeshima T
    Sci Rep; 2019 Jul; 9(1):9900. PubMed ID: 31289281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial.
    Tepper SJ; Grosberg B; Daniel O; Kuruvilla DE; Vainstein G; Deutsch L; Sharon R
    Headache; 2022 Sep; 62(8):989-1001. PubMed ID: 35748757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review.
    Lauritsen CG; Silberstein SD
    Cephalalgia; 2019 May; 39(6):750-760. PubMed ID: 30139273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study.
    Vikelis M; Dermitzakis EV; Spingos KC; Vasiliadis GG; Vlachos GS; Kararizou E
    BMC Neurol; 2017 May; 17(1):97. PubMed ID: 28521762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly
    Przeklasa-Muszyńska A; Skrzypiec K; Kocot-Kępska M; Dobrogowski J; Wiatr M; Mika J
    Neurol Neurochir Pol; 2017; 51(2):127-134. PubMed ID: 28159327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcutaneous Supraorbital Stimulation as a Preventive Treatment for Chronic Migraine: A Prospective, Open-Label Study.
    Ordás CM; Cuadrado ML; Pareja JA; de-Las-Casas-Cámara G; Gómez-Vicente L; Torres-Gaona G; Venegas-Pérez B; Álvarez-Mariño B; Diez Barrio A; Pardo-Moreno J
    Pain Med; 2020 Feb; 21(2):415-422. PubMed ID: 31131857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study.
    Dodick DW; Silberstein SD; Reed KL; Deer TR; Slavin KV; Huh B; Sharan AD; Narouze S; Mogilner AY; Trentman TL; Ordia J; Vaisman J; Goldstein J; Mekhail N
    Cephalalgia; 2015 Apr; 35(4):344-58. PubMed ID: 25078718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial.
    Daniel O; Tepper SJ; Deutsch L; Sharon R
    Pain Ther; 2022 Sep; 11(3):907-922. PubMed ID: 35661128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
    Chou DE; Shnayderman Yugrakh M; Winegarner D; Rowe V; Kuruvilla D; Schoenen J
    Cephalalgia; 2019 Jan; 39(1):3-14. PubMed ID: 30449151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of transcutaneous nerve stimulation for migraine headaches: a systematic review and meta-analysis.
    Evans AG; Horrar AN; Ibrahim MM; Burns BL; Kalmar CL; Assi PE; Brooks-Horrar KN; Kesayan T; Al Kassis S
    J Neurol; 2022 Aug; 269(8):4021-4029. PubMed ID: 35296960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study.
    Kinfe TM; Pintea B; Muhammad S; Zaremba S; Roeske S; Simon BJ; Vatter H
    J Headache Pain; 2015; 16():101. PubMed ID: 26631234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis.
    Lloyd JO; Hill B; Murphy M; Al-Kaisy A; Andreou AP; Lambru G
    J Headache Pain; 2022 Jun; 23(1):63. PubMed ID: 35668368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population.
    Magis D; Sava S; d'Elia TS; Baschi R; Schoenen J
    J Headache Pain; 2013 Dec; 14(1):95. PubMed ID: 24289825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurostimulation of the supraorbital nerve with the Cefaly device - a new method for the treatment of migraine].
    Tabeeva GR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):133-140. PubMed ID: 31089108
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.